---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-121848"
form_type: "8-K"
ticker: null
cik: "0000827871"
company_name: "EAGLE PHARMACEUTICALS, INC."
filed_at: "2023-11-29T23:59:59+00:00"
generated_at: "2026-06-07T20:39:09.023084+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Eagle Pharma receives Nasdaq deficiency notice for delayed Q3 10-Q filing

## Summary
- Nasdaq notified Eagle on Nov 27, 2023 of non-compliance with Rule 5250(c)(1) due to late Q3 10-Q.
- Company has until Jan 26, 2024 to submit a compliance plan; if accepted, Nasdaq may extend to May 7, 2024.
- Failure to regain compliance could lead to delisting; hearing may be requested but no assurance of success.
- No financial impact disclosed; risk of trading suspension or delisting if plan not accepted or filing not made.

## SEC filing metadata
- accession: 0001104659-23-121848
- form_type: 8-K
- cik: 0000827871
- company_name: EAGLE PHARMACEUTICALS, INC.
- filed_at: 2023-11-29T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/827871/000110465923121848/0001104659-23-121848-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/827871/000110465923121848/tm2331615d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-121848
- JSON: https://secwatch.observer/filing/0001104659-23-121848.json
- Plain text: https://secwatch.observer/filing/0001104659-23-121848.txt

## Key facts
- Listing & Compliance Notices
  EAGLE PHARMACEUTICALS, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: late filing
  - Rules: 5250(c)(1)
  source text: rom the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the delay in filing the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the “SEC”). The Notice provides that the Company has 60 calendar days from the date of the Notice, or until January 26, 2024, to submit to Nasdaq a plan
  evidence_url: https://www.sec.gov/Archives/edgar/data/827871/000110465923121848/0001104659-23-121848-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.